ESC Premium Access

Emerging from the darkness: treatment of TTR amyloidosis.

Congress Presentation

About the speaker

Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Madrid (Spain)
33 presentations
5 followers

4 more presentations in this session

Targeting the pathophysiology of hypertrophic cardiomyopathy.

Speaker: Professor I. Olivotto (Florence, IT)

Thumbnail

Imagining a personalised approach to dilated cardiomyopathy.

Speaker: Professor A. Flammer (Zurich, CH)

Thumbnail

Drug treatment of inherited cardiomyopathies – discussion.

Thumbnail

Drug treatment of inherited cardiomyopathies - Chat Moderator.

Thumbnail

Access the full session

Drug treatment of inherited cardiomyopathies

Speakers: Doctor P. Garcia-Pavia, Professor I. Olivotto, Professor A. Flammer
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation

27 August 2021

ESC Premium Access

Case report on a transthyretin-related amyloidosis caused by Leu32Val mutation and its interdisciplinary challenge.

27 August 2021

ESC Premium Access

A case of cardiac amyloidosis initially mis-diagnosed as BRASH syndrome.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk